143 results
Page 3 of 8
8-K
EX-99.1
dhg3ihbyrse0t
5 Nov 20
Adaptimmune Reports Q3 Financial Results and Business Update
7:40am
8-K
EX-99.1
ndd83rkz
15 Oct 20
Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
4:47pm
8-K
EX-99.1
uhr3bx7a5zs
28 Aug 20
Regulation FD Disclosure
10:44am
S-3ASR
4mzbhgb7xea47jctl94
10 Aug 20
Automatic shelf registration
5:01pm
424B5
f3a5tz
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
50btlqu
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
u4mmps74z667elo2
29 May 20
Regulation FD Disclosure
7:42am
8-K
EX-99.1
2g3q7 8qtk
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
EX-99.1
6jxdo3
29 Apr 20
Other Events
8:06am
8-K
7mvsbdoqtn 0j
29 Apr 20
Other Events
8:06am
8-K
EX-99.1
zqn5dnobv6ojz
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
424B5
2rvblc
22 Jan 20
Prospectus supplement for primary offering
5:31pm
424B5
4qzdb1dbg30zc05q9vnp
21 Jan 20
Prospectus supplement for primary offering
5:21pm